Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1998-03-31
1999-07-06
Sayala, Chhaya D.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 2, 514 12, 514 21, 530399, A61K 3818
Patent
active
059197595
ABSTRACT:
This invention relates to a method of promoting angiogenesis utilizing scatter factor, either alone or in combination with a growth factor.
REFERENCES:
patent: 5136025 (1992-08-01), Scheuermann et al.
Biosis AN 94: 112260, Yoshinaga et al., Japanese Journal of Cancer Research, 84(11), 1150-58 (abstract), 1993.
Cancerlit AN 93016275, Bussolino et al., Journal of Cell Biology, vol. 119, No. 3, 629-41 (abstract), 1992.
Bhargava et al., in Cell Growth Differ., vol. 3, pp. 11-20 (1992).
Weidner et al., in Proc. Nat'l. Acad. Sci. USA, vol. 88, pp. 7001-7005 (1991).
Montesano et al., in Cell, vol. 67, pp. 901-908 (1991).
Bottaro et al., in Science, vol. 251, pp. 802-804 (1991).
Naldini et al., in Oncogene, vol. 6, pp. 501-504 (1991).
Rosen et al., in Cell Motility Factors, (Birkhauser, Basel) pp. 76-88 (1991).
Rubin et al., in Proc. Nat'l. Adad. Sci. USA, vol. 88, pp. 415-419 (1991).
Bhargava et al., in Cell Motility Factors, (Birkhauser, Basel) pp. 63-75 (1991).
Rosen et al., in Proc. Soc. Exp. Biol. Med., vol. 195, pp. 34-43 (1990).
Rosen et al., in In Vitro Cell Dev. Biol., vol. 25, pp. 163-173 (1989).
Miyazawa et al., in Biochem, Biophys. Res. Commun., vol. 169, pp. 967-973 (1989).
Nakamura et al., in Nature (London), vol. 342, pp. 440-443 (1989).
Grant et al., in Cell, vol. 58, pp. 933-943 (1989).
Griffiths et al., in Am. Acad. Dermatol., vol. 20, pp. 617-629 (1989).
Saksela et al., in Anu. Rev. Cell Biol., vol. 4, pp. 93-126 (1988).
Stoker et al., in J. Cell Sci., vol. 77, pp. 209-223 (1985).
Stoker et al., in Nature (London), vol. 327, pp. 238-242 (1987).
Folkman et al., in Adv. Cancer Res., vol. 43, pp. 175-203 (1985).
Ingber et al., in Cell, vol. 58, pp. 803-805 (1985).
Polson et al., in Immunol. Commun., vol. 9, pp. 495-514 (1980).
Polverini et al., in Lab. Invest., vol. 51, pp. 635-642 (1984).
Yoshinaga, et al., Japanese Journal of Cancer Research, 84(11), 1993, 1150-1158.
Grant et al., PNAS (USA), vol. 90, pp. 1937-1941, Mar. 1993.
Bussolino et al., J. Cell. Biol., vol. 119(3), pp. 629-641, Nov. 1992.
Furcht et al., Lab. Invest., vol. 55(5), pp. 505-509, 1986.
Igawa et al., Biochem. Biophy. Res. Commun., vol. 174(2), pp. 831-838, 1991.
Shima et al., Cell Biol. Int. Rep., vol. 15(5), pp. 397-408, 1991.
Gherardi et al., PNAS, vol. 86, pp. 5844-5848, 1989.
Folkman et al., Science, vol. 235, pp. 442-447, 1987.
Arakaki et al., Biochem. Biophy. Res. Commun., vol. 185(1), pp. 22-28, 1992.
Tamura et al., J. Biol. Chem., vol. 268(11), pp. 8140-8145, 1993.
Goldberg Itzhak D.
Rosen Eliot M.
North Shore University Hospital Research Corporation
Sayala Chhaya D.
LandOfFree
Use of scatter factor to enhance angiogenesis does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of scatter factor to enhance angiogenesis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of scatter factor to enhance angiogenesis will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-899035